Milan Cheeks – Trademark Portfolio
Entity Type: 01
Milan Cheeks has 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include SYMBOL. The portfolio includes 1 registered trademark. Filings span 6 Nice Classification classes, led by Class 36 (Insurance & Financial) and Class 42 (Computer & Scientific). This trademark owner is based in Ronkonkoma, NY.
16 New Rd
Ronkonkoma, NY 11779
Showing of trademarks Trademarks
Trademark Classifications
Milan Cheeks's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Milan Cheeks have?
Milan Cheeks has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned.
What trademark classes does Milan Cheeks file in?
Milan Cheeks files trademarks across 6 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 37 (Building & Construction). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Milan Cheeks's most well-known trademarks?
Milan Cheeks's registered trademark portfolio includes well-known marks such as SYMBOL. These are among 1 currently registered trademark in the portfolio.
What is Milan Cheeks's trademark registration success rate?
Milan Cheeks has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.